mesalamine delayed-release tablets

mesalamine delayed-release tablets
SPL v7
SPL
SPL Set ID 52d96501-47f3-45d8-a181-98763b9f8965
Route
oral
Published
Effective Date 2024-07-27
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
mesalamine (800 mg)
Inactive Ingredients
acetyltributyl citrate silicon dioxide ferric oxide red magnesium stearate methacrylic acid cellulose, microcrystalline povidone sodium starch glycolate type a potato talc titanium dioxide ferrosoferric oxide isopropyl alcohol butyl alcohol propylene glycol ammonia shellac

Identifiers & Packaging

Pill Appearance
Imprint: 435 Shape: capsule Color: red Size: 19 mm Score: 1
Marketing Status
anda active Since 2018-08-02

Description

NDC 70771-1110-8 in bottle of 180 tablets Mesalamine Delayed-release Tablets USP, 800 mg R x only 180 tablets


Medication Information

Description

NDC 70771-1110-8 in bottle of 180 tablets Mesalamine Delayed-release Tablets USP, 800 mg R x only 180 tablets

Package Label.principal Display Panel

NDC 70771-1110-8 in bottle of 180 tablets

Mesalamine Delayed-release Tablets USP, 800 mg

Rx only

180 tablets


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1110-8 in bottle of 180 tablets

Mesalamine Delayed-release Tablets USP, 800 mg

Rx only

180 tablets


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)